Oritavancin for CIED Infections With MDR Gram-positive Cocci
Oritavancin for CIED Infections With MDR Gram-positive Cocci
Not yet recruiting · NCT07013552 · Registry updated 2025-06-10Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Oritavancin for CIED Infections With MDR Gram-positive Cocci | Bacterial Infections and Mycoses, Disease Attributes, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, bacterial infectious disease, cardiovascular disorder, endocarditis, gram-positive bacterial infections, heart disorder, iatrogenic disease, infective endocarditis, nosocomial infection | Not yet recruiting | Not applicable | 2025-06-10 | NCT07013552 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Medical Research Agency, Poland | 33 |
| Medical University of Silesia | 27 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Department of Electrocardiology and Heart Failure, Medical University of Silesia in Katowice | Katowice | Poland | 1 |